Paediatric Clinical Trials Conference

March 20-21, 2017 - London, United Kingdom

Conference Proceedings

Standard Price

US$ 623.75

User Details



We are proud to present the return of our 11th annual Paediatric Clinical Trials Conference, 20th - 21st March 2016, London.

The field of paediatric medicines is advancing and the push has been to make medicines child size, however approximately two thirds of medicinal products that are prescribed for children have not been adequately studied and recommended for paediatric use

Strengthening strategies in paediatric investigation plans remains paramount and with the EMA 10 year review of paediatric regulation a call has been made for greater guidance with the goal of increasing the number of safe paediatric therapeutics on the market.

Join us as we discuss current clinical trials, implementation and paediatric drug development in a series of interactive conference sessions, roundtables and workshops led by leading industry experts. Gain information on methods to improve clinical recruitment, appreciate ethical issues and navigate regulations when planning and executing a paediatric clinical trial. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints.


Benefits of Attending

  • Review and discuss paediatric clinical trial Legislation in the EU and globally
  • Explore the practical costs and safety considerations of conducting a paediatric clinical trial
  • Review the challenges in paediatric drug development for oncology drugs and vaccines
  • Optimise your approach to paediatric formulation to improve clinical success
  • Evaluate approaches for recruitment and retention


Plus Interactive Half-Day Post-Conference Workshop | Wednesday 22nd March 2017

Paediatric drug development: Paediatric Investigation Plans (PIPs), challenges and strategies
Workshop Leader: Klaus Rose, CEO, Klausrose Consulting
08.30 - 13.00

Speakers

  • Andy Kenwright, Senior Statistical Scientist, Hoffmann-La Roche Limited
  • Bianca McDade, Director, Regulatory Affairs, GSK
  • Bobby Gaspar, Head of Paediatrics and Immunology , Ucl Hospitals
  • Cecile De Coster, Associate Director, Regulatory Affairs, Alexion Pharmaceuticals
  • Deborah Lee, VP, Clinical Development, Insys Therapeutics, Inc.
  • Floriane Sequier, Senior Scientist, Astrazeneca
  • Genevieve Michaux, Member of the Brussels and Paris Bar, Partner, mayer brown llp
  • Hernando Patino, Senior Medical Director, Johnson & Johnson
  • Jane Lamprill, Paediatric Research Consultant Specialist Medical Writer for Children and Member FP7 Ethics Panel, Paediatric Research Consultancy
  • Karl-Heinz Huemer, Scientific Office, Austrian Agency for Health and Food Safety
  • Kerry Leeson-Beevers, Patient Representative, Paediatric Committee, EURODIS
  • Klaus Rose, CEO, klausrose Consulting
  • Larissa Kerecuk, Rare Disease Lead for BCH, The Birmingham Childrens Hospital
  • Philippe Auby, CEO & President, OEDC, Otsuka Europe Development and Commercialisation Ltd
  • Robert Kahn, Former Senior Safety Science Leader, Global Pediatric Oncology, Genentech
  • Tom Willgoss, Senior Outcomes Research Scientist , Roche Products

Please fill in your name and email to receive the conference agenda of this event.


The agenda is available as PDF under dwonloads at the right side of the page.

Venue

Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK

Who Should Attend?

Directors, Chiefs, VPs, Heads, Managers, Principals of:
  • Clinical Trials/ Paediatric
  • Clinical Research
  • Regulatory Affairs
  • Clinical Operations
  • (Paediatric) Drug Development
  • Drug Formulation


Venue

Copthorne Tara Hotel
Scarsdale Place, Kensington
London, United Kingdom
Event details
Organizer :SAE Media Group
Event type :Conference
Attendance :Physical Event
Reference :ASDE-15640